SUMAYYAH RAZZAQ: Open Payments
NPI 1609499698 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 31 payments from 16 companies in 2025. Trend: 2023 $109 · 2024 $444 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $122 |
| Lilly USA, LLC | 4 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $40 |
| Dexcom, Inc. | 2 | $30 |
| Amgen Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
Products named: MOUNJARO, LINZESS, GEMTESA, Veozah, AIRSUPRA, VRAYLAR, Dexcom G6 Transmitter, REXULTI.
Industry payments across NC — which companies pay providers there.
